琥珀酸与12,13-diHOME与肥胖及代谢特征呈负相关:大型横断面研究
在2248名成年人中,血浆琥珀酸和12,13-diHOME水平每升高1个标准差,分别与总脂肪量降低0.15和0.08个标准差相关;12,13-diHOME还与空腹胰岛素和甘油三酯降低相关。孟德尔随机化分析未发现遗传决定的BMI或代谢异常影响这两种代谢物水平。
要点
- 血浆琥珀酸和12,13-diHOME水平越高,总脂肪量越低。
- 12,13-diHOME水平越高,空腹胰岛素和甘油三酯越低。
- 遗传决定的BMI、高胰岛素血症和血脂异常不改变这两种代谢物水平。
核心结论
- 血浆琥珀酸和12,13-diHOME可能与人类能量代谢调节和棕色脂肪组织激活有关。
研究设计与样本
- 在2248名个体(50%女性,平均年龄41.3±5.9岁,平均BMI 26.1±4.6 kg/m2)中开展横断面研究。
- 采用超高效液相色谱-串联质谱法测定空腹血浆琥珀酸和12,13-diHOME水平。
- 采用双能X射线吸收法评估全身和区域肥胖程度。
- 采用年龄和性别校正的线性回归模型分析代谢物与体成分及代谢特征的关联。
- 采用两样本孟德尔随机化评估遗传决定的BMI和代谢特征与血浆代谢物水平的关联。
主要发现
- 血浆琥珀酸浓度每升高1个标准差,总脂肪量降低0.15个标准差(95%CI 0.28,0.03)。
- 血浆12,13-diHOME浓度每升高1个标准差,总脂肪量降低0.08个标准差(95%CI 0.15,0.01)。
- 血浆12,13-diHOME每升高1个标准差,空腹血浆胰岛素降低0.09个标准差(95%CI 0.16,0.02)。
- 血浆12,13-diHOME每升高1个标准差,血浆甘油三酯降低0.10个标准差(95%CI 0.17,0.04)。
- 孟德尔随机化分析中,遗传决定的较高BMI、空腹高胰岛素血症和血脂升高与两种血浆代谢物浓度变化无关,未检测到方向性多效性偏倚。
临床怎么用
- 目前尚不能将血浆琥珀酸或12,13-diHOME作为常规临床指标用于评估肥胖或代谢风险。
- 这些发现提示促进棕色脂肪组织激活的代谢物可能对全身代谢有益,但需直接评估棕色脂肪活性和膳食补充的进一步研究。
局限性
- 横断面设计无法推断因果关系。
- 未直接评估棕色脂肪组织活性。
- 孟德尔随机化分析未发现遗传决定的BMI和代谢特征影响代谢物水平,提示观察到的关联方向可能复杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Circulating succinate and 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) were recently shown to promote brown adipocyte thermogenesis and protect against metabolic disorders in rodents. This study aimed to evaluate the associations between plasma levels of these metabolites and adiposity and metabolic profile in humans. METHODS: Fasting plasma succinate and 12,13-diHOME levels were quantified using ultra HPLC-tandem MS in 2248 individuals (50% female, mean age 41.3 ± 5.9 years, mean BMI 26.1 ± 4.6 kg/m2) in addition to fasting plasma biochemistry. Total and regional adiposity were assessed with dual-energy x-ray absorptiometry. An age- and sex-adjusted linear regression model was used to determine the associations between succinate and 12,13-diHOME levels and body composition and metabolic profile. Two-sample Mendelian randomisation was used to assess the associations between genetically determined BMI and metabolic traits with circulating plasma succinate and 12,13-diHOME. RESULTS: A one-SD higher plasma succinate and 12,13-diHOME concentration was associated with a 0.15 SD (95% CI 0.28, 0.03) and 0.08 SD (0.15, 0.01) lower total fat mass respectively. Additionally, a one-SD higher plasma 12,13-diHOME level was associated with a 0.09 SD (0.16, 0.02) lower fasting plasma insulin and 0.10 SD (0.17, 0.04) lower plasma triacylglycerol. In Mendelian randomisation analyses, genetically determined higher BMI, fasting hyperinsulinaemia and elevated lipid levels were not associated with changes in either plasma succinate or plasma 12,13-diHOME concentrations. No indications of bias due to directional pleiotropy were detected in the Mendelian randomisation analyses. CONCLUSIONS/INTERPRETATION: Our findings tentatively suggest that plasma succinate and 12,13-diHOME may play a role in the regulation of energy metabolism and brown adipose tissue activation in humans. Further studies encompassing direct assessment of brown adipose tissue activity and dietary supplementation are necessary to investigate the potential beneficial effects of these metabolites on systemic metabolism.
引用
- Vasan SK, Noordam R, Gowri MS, et al. The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study. Diabetologia. 2019. PMID: 31309263. doi:10.1007/s00125-019-4947-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。